Split-hand sign is a useful clinical and electrophysiological feature in the diagnosis of amyotrophic lateral sclerosis (ALS). We proposed a novel split-hand index (SI) using F-wave persistence (FP) and assessed its diagnostic utility in ALS. Eighty-three consecutive ALS patients were recruited, and 50 healthy, age-, and height-matched volunteers were used as a control group. Compound muscle action potentials (CMAP) and FP were recorded from the abductor pollicis brevis (APB), first dorsal interosseous (FDI), and the abductor digiti minimi (ADM) muscles. The SI derived from FP was calculated using the following formula: SI = (FP ×FP)/FP. The sensitivity and specificity of SI and SI in differentiating ALS from healthy controls (HCs) were derived from receiver-operating characteristic (ROC) curve analysis. Both SI and SI were significantly reduced in ALS patients. The ROC curve analysis indicated that both SI and SI reliably differentiated ALS from HCs [0.92 (95% CI: 0.88-0.95); 0.86 (95% CI: 0.82-0.91)], but SI showed better diagnostic accuracy than SI ( = 0.04), with a high sensitivity (81.2%) and specificity (97%). In subgroup analyses, SI appeared to be a better variable than SI for differentiation of ALS patients with normal CMAP from HCs, with an area under the curve of 0.87 (95% CI: 0.80-0.93), sensitivity of 69.4%, and specificity of 94%. The SI reliably distinguished ALS patients from HCs and may be more sensitive for determining the split-hand pattern of ALS than SI, particularly in the early stage of the disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/21678421.2019.1646770 | DOI Listing |
Infect Dis Rep
December 2024
Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli 620024, India.
Indwelling intrauterine contraceptive devices (IUDs) have surfaces that facilitate the attachment of spp., creating a suitable environment for biofilm formation. Due to this, vulvovaginal candidiasis (VVC) is frequently linked to IUD usage, necessitating the prompt removal of these devices for effective treatment.
View Article and Find Full Text PDFBiosensors (Basel)
November 2024
Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Transactive response DNA-binding protein of 43 kDa (TDP-43) is a major component of pathological inclusions in various neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The detection of TDP-43 in biofluids is crucial for the development of diagnostic and prognostic indicators of disease and therapeutic development for TDP-43-related proteinopathies. Despite its potential as a biomarker for numerous neurological disorders, the lack of a sensitive and reproducible TDP-43 assay hinders progress in TDP-43-based therapy development, underscoring the need for an effective and standardized method for accurate quantification.
View Article and Find Full Text PDFAm J Physiol Cell Physiol
December 2024
Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Norway.
Amyotrophic lateral sclerosis (ALS) is characterized by dysfunction and loss of upper and lower motor neurons. Several studies have identified structural and functional alterations in the motor neurons before the manifestation of symptoms, yet the underlying cause of such alterations and how they contribute to the progressive degeneration of affected motor neuron networks remain unclear. Importantly, the short and long-term spatiotemporal dynamics of neuronal network activity make it challenging to discern how ALS-related network reconfigurations emerge and evolve.
View Article and Find Full Text PDFCell Mol Life Sci
December 2024
Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.
The development of ground-breaking Survival Motor Neuron (SMN) replacement strategies has revolutionized the field of Spinal Muscular Atrophy (SMA) research. However, the limitations of these therapies have now become evident, highlighting the need for the development of complementary targets beyond SMN replacement. To address these challenges, here we explored, in in vitro and in vivo disease models, Stathmin-2 (STMN2), a neuronal microtubule regulator implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), as a novel SMN-independent target for SMA therapy.
View Article and Find Full Text PDFBMJ Open
December 2024
Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
Background: Although rare, uterine sarcomas account for a high proportion of uterine cancer mortality. Treatment options and robust trial data are limited.
Objectives: The TOURISM study (Treatment Outcomes in UteRIne SarcoMa) is a UK-wide study by the National Oncology Trainees Collaborative for Healthcare Research which aimed to characterise this patient cohort.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!